tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Kyverna Therapeutics Inc

KYTX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
5.050USD
+0.020+0.40%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
312.29M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

KYTX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Kyverna Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
312.29M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-1.54
์ฃผ๋‹น์ˆœ์ด์ต
-3.27
์ˆ˜์ต
--
์ˆœ์ด์ต
-127.48M
ROE
-74.55%
ROA
-60.42%
Kyverna Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Nov 12, 2026
EPS / ์˜ˆ์ƒ
-0.68/-0.69
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
20.11%-0.68
35.37%-0.63
36.35%-0.66
7.61%-0.80
-6.02%-0.85
-45.76%-0.97
-66.83%-1.03
-109.77%-0.87
---0.80
---0.67
-126.81%-0.62
-98.63%-0.41
----
----
---0.27
---0.21
---0.50
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--282.00K
----
์ˆœ์ด์ต
-14.01%-41.94M
8.94%-38.32M
10.99%-39.73M
-0.84%-37.80M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
----
----
---11.14M
---8.50M
----
์ˆœ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---3012.77%
---302.49%
์ด ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
๋ถ€์ฑ„๋น„์œจ
12370.22%13.19%
8003.77%11.38%
4276.94%9.74%
2720.01%8.53%
-69.28%0.11%
-63.85%0.14%
-47.28%0.22%
-87.89%0.30%
-83.88%0.34%
--0.39%
--0.42%
--2.50%
--2.14%
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--282.00K
----
์˜์—… ์ด์ต
-9.48%-42.40M
10.93%-39.56M
11.62%-41.37M
4.29%-39.28M
0.11%-38.73M
-32.82%-44.41M
-59.44%-46.81M
-91.99%-41.04M
---38.77M
---33.44M
-156.51%-29.36M
-143.61%-21.38M
----
----
---11.45M
---8.78M
----
์ˆœ์ด์ต
-14.01%-41.94M
8.94%-38.32M
10.99%-39.73M
-0.84%-37.80M
-6.65%-36.79M
-46.10%-42.08M
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
----
----
---11.14M
---8.50M
----
์œ ๋™์ž์‚ฐ
0.76%176.26M
-3.63%206.54M
-2.39%241.73M
-2.63%282.95M
-46.24%174.93M
-38.56%214.33M
-34.05%247.65M
379.03%290.60M
309.74%325.37M
--348.82M
--375.49M
--60.66M
--79.41M
----
----
----
----
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-25.79%25.14M
-42.69%22.80M
-10.87%29.67M
8.09%36.49M
9.31%33.87M
69.47%39.79M
52.26%33.29M
69.98%33.76M
83.63%30.98M
--23.48M
--21.86M
--19.86M
--16.87M
----
----
----
----
์ด ์ž์‚ฐ
1.22%189.44M
-2.95%219.82M
-1.39%257.02M
-3.55%293.83M
-44.82%187.16M
-37.62%226.51M
-33.16%260.65M
305.14%304.64M
266.75%339.20M
--363.12M
--389.98M
--75.19M
--92.49M
----
----
----
----
๋ถ€์ฑ„ ์ด๊ณ„
59.85%56.28M
28.82%54.27M
67.67%61.44M
61.73%61.55M
-3.50%35.21M
42.30%42.13M
26.39%36.65M
46.28%38.06M
53.83%36.49M
--29.61M
--28.99M
--26.02M
--23.72M
----
----
----
----
์ž๋ณธ ์ด๊ณ„
-12.37%133.15M
-10.21%165.55M
-12.69%195.58M
-12.87%232.28M
-49.80%151.95M
-44.72%184.38M
-37.95%224.01M
442.10%266.59M
340.19%302.71M
--333.51M
--360.99M
--49.18M
--68.77M
----
----
----
----
์ˆœ์˜์—…์ด์ต
18.36%-35.37M
-26.16%-40.31M
7.39%-41.60M
9.54%-33.53M
-57.59%-43.32M
-32.16%-31.95M
-75.96%-44.91M
-99.65%-37.06M
---27.49M
---24.18M
-122.77%-25.52M
-110.54%-18.56M
----
----
---11.46M
---8.82M
----
์ˆœํˆฌ์ž
26.45%28.52M
23.87%36.13M
-999.98%-50.20M
-159.16%-17.29M
3236.83%22.56M
142.94%29.17M
104.54%5.58M
-7.76%29.22M
--676.00K
---67.92M
-999.88%-122.88M
109.16%31.68M
----
----
--13.65M
--15.15M
----
์ˆœ์žฌ๋ฌดํ™œ๋™
360.75%6.86M
683.67%3.79M
75.60%-101.00K
65561.86%140.74M
1078.95%1.49M
-14.06%-649.00K
-100.12%-414.00K
85.01%-215.00K
---152.00K
---569.00K
234856.25%338.05M
-1305.88%-1.43M
----
----
---144.00K
---102.00K
----

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Kyverna Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 282.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2.63์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 293.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3.55์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 61.55M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 61.73์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 232.28M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -12.87์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -169.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -18.67์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 40.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 124.87์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Kyverna Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 141.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -58.12์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.64์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.60์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -161.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -26.54์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 8.53์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2720.10์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -64.67์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 65.71์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -53.91์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.69์ž…๋‹ˆ๋‹ค.

Kyverna Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Kyverna Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -169.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -18.67์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ